MARÍA LUISA
NAVARRO GÓMEZ
Profesora asociada de Ciencias de la Salud
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario 12 de Octubre (103)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohort
BMC Infectious Diseases, Vol. 24, Núm. 1
-
The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios
Vaccines, Vol. 12, Núm. 1
-
Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain
Pediatric Infectious Disease Journal, Vol. 43, Núm. 1, pp. 40-48
-
Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study
Clinical Infectious Diseases, Vol. 79, Núm. 1, pp. 215-222
2023
-
Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations
Anales de Pediatria, Vol. 98, Núm. 1, pp. 58.e1-58.e10
-
Increased risk of group B streptococcal sepsis and meningitis in HIV-exposed uninfected infants in a high-income country
European Journal of Pediatrics, Vol. 182, Núm. 2, pp. 575-579
-
Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019
Pediatrics, Vol. 152, Núm. 4
-
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy
Biomedicine and Pharmacotherapy, Vol. 162
-
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
eClinicalMedicine, Vol. 60
-
Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio
Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 3, pp. 143-151
2022
-
Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children
European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115
-
Factors associated with late presentation for HIV care in adolescents in Spain
HIV Medicine, Vol. 23, Núm. 11, pp. 1195-1201
-
Immunisation schedule of the Pediatric Spanish Association: 2022 recommendations
Anales de Pediatria, Vol. 96, Núm. 1, pp. 59.e1-59.e10
-
Integrase inhibitors in children and adolescents: Clinical use and resistance
Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 10, pp. 2784-2792
-
New diagnosis of mother-to-child transmission of HIV in 8 Latin-American countries during 2018
BMC Infectious Diseases, Vol. 22, Núm. 1
-
Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial
Frontiers in Pediatrics, Vol. 10
-
Pregnancy Outcomes Among Perinatally HIV-Infected Women in Spain
Journal of acquired immune deficiency syndromes (1999), Vol. 91, Núm. 4, pp. 373-380
-
Prevalence of psychological symptoms and associated risk factors in a Spanish sample of HIV-positive youth compared to uninfected peers
Anales de Pediatria, Vol. 96, Núm. 3, pp. 203-212
-
Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort
Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768